British scientists announced yesterday that obesity may be in the future with a gum made from an intestinal hormone, known as pancreatic polypeptide, which reproduces the feeling of satiety.
(AP) Researchers, led by Steve Bloom of Imperial College London are developing a drug with the said hormone. They estimate that in five years could be available in the form of an injectable treatment, they said. However, its objective is to develop a drug that can be absorbed through the mouth to incorporation into a chewing gum added. They also study the possibility of being administered through a nasal inhaler.
Early trials suggest that moderate doses of the hormone can be reduced from 15 to 20 percent the amount of food eaten by healthy volunteers.
Mice administered with the compound lost 15 percent of their weight in just one week. In England, 30,000 people die each year because of obesity, associated with conditions such as diabetes and heart disease.
currently available drugs have undesirable side effects and must be managed carefully. "A treatment based on a natural appetite suppressant, which simulates the sensation of fullness of the body itself has the potential to be safe and effective. We believe that pancreatic polypeptide may be the answer," said Bloom.
The body produces this hormone at the end of each meal to ensure that food intake is not excessive. However, there are people who produce less than others, and in any case, production is reduced if you are overweight.